Educational Overview
Migraine Treatment Options: Why Doctors Try Things in This Order
This page explains how migraine treatments are categorized by mechanism - helping you understand why different options exist, why they're sequenced the way they are, and why response varies from person to person.
Quick Answer
Why does migraine treatment feel so confusing?
Migraine treatments target different parts of a complex system. Because migraine involves nervous system excitability, vascular signaling, and pain processing, treatments are organized by which mechanism they influence - not by 'strength' or severity. Insurance step therapy adds another layer by requiring certain categories before others.
This page explains migraine treatment options by mechanism - including antidepressants, beta blockers, CGRP medications, Botox, and neuromodulation - and why insurance often requires them to be tried in a specific order.
Important context
This page explains how migraine is typically treated in conventional medical care - including how medications are categorized and why they're often tried in a specific order.
It is not a list of treatments endorsed or provided by the Migraine Detective Method. The purpose here is to help you understand the system many patients move through, so you can interpret your experience within it - even if you ultimately take a different approach.
Why Treatment Feels Arbitrary
If you've cycled through multiple migraine treatments without clear answers, you're not alone. The experience often feels arbitrary - medications prescribed without explanation, stopped without resolution, replaced without understanding why.
This confusion doesn't mean migraine is poorly understood. It means migraine is a complex, multi-system condition, and treatment involves matching interventions to patterns that vary between individuals.
Adding to this complexity: insurance coverage often requires step therapy - documented trials of certain categories before others can be approved. Understanding why this sequencing exists can reduce frustration and help you see the logic behind what may feel like random experimentation.
One Way to Make Sense of It
Migraine treatments can be grouped by what part of the system they're trying to influence - not by how "strong" they are or how severe the migraine is. A treatment that targets nervous system excitability works differently than one that targets vascular signaling, which works differently than one that blocks migraine-specific pathways. None is inherently better; each addresses a different piece of the puzzle.
How Treatments Are Grouped
Rather than listing medications by name or "strength," the categories below organize treatments by which part of the migraine system they're designed to influence. This makes it easier to understand why certain options are tried before others - and why response varies.
1. Treatments That Lower Baseline Nervous System Excitability
Examples: tricyclic antidepressants, SNRIs, anti-seizure medications
The migraine-prone brain tends to be more reactive to stimuli than average. These treatments aim to raise the threshold at which the nervous system responds - reducing the overall "excitability" of the system.
Because they affect broad neurological pathways, they often have effects beyond migraine (on mood, sleep, or nerve pain). This can be helpful or limiting depending on the individual.
These are frequently tried first because they're well-studied, widely available, and address a foundational aspect of migraine physiology. Partial response or side effects are common - not because the treatment is wrong, but because it's influencing a broad system.
2. Treatments That Stabilize Vascular or Autonomic Signaling
Examples: beta blockers, calcium channel blockers
Migraine involves changes in blood vessel tone and autonomic nervous system regulation - the systems that control heart rate, blood pressure, and vascular responsiveness.
For people whose migraine patterns correlate with blood pressure fluctuations, heart rate variability, or autonomic instability (lightheadedness, temperature sensitivity, postural symptoms), these treatments may address a relevant mechanism.
They help some patterns significantly and others not at all - reflecting the variability of what drives migraine in different individuals.
3. Treatments That Target Migraine-Specific Signaling Pathways
Examples: CGRP-targeting therapies (monoclonal antibodies, gepants)
CGRP (calcitonin gene-related peptide) is a molecule specifically involved in migraine signaling. Treatments that block CGRP or its receptors are designed to interrupt a pathway known to be active during migraine attacks.
These are often tried later - not because they're "stronger," but because they're more targeted and more expensive. Insurance typically requires documentation that broader treatments were tried first.
Being more specific doesn't guarantee effectiveness. If CGRP isn't the primary driver of someone's pattern, a CGRP-blocking treatment may show limited benefit - without meaning the migraine is "treatment-resistant."
4. Treatments That Reduce Peripheral Input Into the System
Examples: onabotulinumtoxinA (Botox), nerve blocks, neuromodulation devices
The brain receives constant sensory input from muscles, nerves, and tissues in the head and neck. In chronic migraine, this input may contribute to maintaining an elevated state of sensitivity.
These treatments aim to reduce the volume of incoming signals - calming the system by limiting what it has to process.
They're often used in chronic migraine patterns (15+ headache days per month) where the system appears to be in a sustained sensitized state.
5. Acute vs. Preventive Treatments
A fundamental distinction exists between treatments designed to stop an attack in progress (acute/abortive) and treatments designed to reduce the frequency or severity of future attacks (preventive).
Acute Treatments
Interrupt an attack that has started. Examples include triptans, gepants (when used acutely), and NSAIDs. Timing matters - earlier intervention often means better response.
Preventive Treatments
Taken regularly to reduce attack frequency over time. Effects often take weeks to months to evaluate. Most categories above (1-4) are preventive.
Confusion between these categories leads to frustration. A preventive treatment isn't "failing" because it doesn't stop today's attack; an acute treatment isn't a long-term solution if attacks remain frequent.
Why Insurance Requires Step Therapy
Step therapy is an insurance requirement that patients try certain treatment categories before others are covered. This sequencing is based on cost and evidence tiers - not on treatment strength or migraine severity.
Less expensive, broader-acting treatments are typically required first. Documentation of their trial (and limited response) is needed before newer, more targeted options are approved.
This system can feel like bureaucratic obstruction - and sometimes it is. But understanding it can help: knowing that documentation matters, that "failure" of one category opens doors to others, and that the sequence reflects cost structures rather than clinical judgment about your migraine.
When It Feels Like Nothing Has Worked
When treatments don't produce the expected result, it's easy to conclude that migraine is "treatment-resistant" or that nothing will ever help. But treatment response in migraine is rarely all-or-nothing.
Common patterns that look like failure:
- •Partial response - Attacks are less severe or slightly less frequent, but still present. This may indicate the treatment is addressing part of the pattern.
- •Delayed improvement - Preventive treatments often take 8-12 weeks to show effect. Stopping too early can look like non-response.
- •Inconsistent benefit - The treatment helps some attacks but not others. This reflects migraine's state-dependent nature - different attacks may have different drivers.
- •Wrong mechanism targeted - The treatment may be well-designed but not matched to what's driving your specific pattern.
Migraine operates as a state-dependent, threshold-based system. Response to treatment depends not just on the medication, but on the state of the system when it's applied. This explains why the same treatment can work one month and not another - and why apparent "failure" may reflect timing, dosing, or pattern mismatch rather than true non-response.
What This Page Covers - and What It Doesn't
This page explains:
- •Why different treatment categories exist
- •Why treatments are sequenced by insurance
- •Why response varies between individuals
- •Why "failure" is often more nuanced than it appears
This page does not explain:
- •Which treatment you should choose
- •Dosing or drug selection
- •When to start or stop medications
- •Emergency care decisions
- •Which treatments the Migraine Detective Method recommends or prioritizes
All treatment decisions should be made with a licensed clinician who knows your history.
Where to Go Next
For deeper context on why migraine behaves the way it does - and why treatment response varies:
Why do the same triggers cause migraines some days but not others?
The threshold model that explains variable response
Why do migraines become frequent or chronic over time?
Understanding escalation and sensitization patterns
Why does doing everything right still not prevent attacks?
When discipline isn't enough
Why does migraine prevention sometimes help but not stop attacks?
Evaluating partial response and delayed improvement
If this feels frustrating, that's normal. Most people with migraines aren't missing discipline or willpower - they're dealing with overlapping systems that shift over time and don't show up on standard tests.
Not sure which direction fits your situation?
You can start with a quick assessment or go deeper with the AI.
Educational pattern exploration, not medical advice.